e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 7, 2010 (May 5, 2010)
EXPRESS SCRIPTS, INC.
(Exact Name of Registrant as Specified in its Charter)
         
DELAWARE   0-20199   43-1420563
(State or Other Jurisdiction of   (Commission File Number)   (I.R.S. Employer
Incorporation or Organization)       Identification No.)
         
One Express Way, St. Louis, MO       63121
(Address of Principal Executive Offices)       (Zip Code)
Registrant’s telephone number including area code: 314-996-0900
No change since last report
(Former Name or Address, if Changed Since Last Report)
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 5.07. Submission of Matters to a Vote of Security Holders.
On May 5, 2010, Express Scripts, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). Of the 274,888,321 shares outstanding and entitled to vote, 244,661,350 shares were represented at the meeting, or an 89% quorum. The final results for each of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:
Proposal 1. Election of Directors. All of management’s nominees for director were elected to serve until the next Annual Meeting of Stockholders or until their respective successors are elected and qualified, by the votes set forth in the table below.
                                 
                            BROKER
NOMINEE   FOR   AGAINST   ABSTAIN   NON-VOTES
Gary G. Benanav
    220,775,487       6,648,752       114,508       17,122,603  
Frank J. Borelli
    224,823,098       2,601,913       113,736       17,122,603  
Maura C. Breen
    226,664,094       767,625       107,028       17,122,603  
Nicholas J. LaHowchic
    226,542,990       880,611       115,146       17,122,603  
Thomas P. Mac Mahon
    226,650,495       775,090       113,162       17,122,603  
Frank Mergenthaler
    226,611,774       813,791       113,182       17,122,603  
Woodrow A. Myers, Jr. M.D.
    224,303,940       3,121,949       112,858       17,122,603  
John O. Parker, Jr.
    226,645,413       779,568       113,766       17,122,603  
George Paz
    218,668,674       8,715,481       154,592       17,122,603  
Samuel K. Skinner
    221,912,279       5,445,782       180,686       17,122,603  
Seymour Sternberg
    215,982,857       11,442,384       113,506       17,122,603  
Barrett A. Toan
    226,290,026       1,135,583       113,138       17,122,603  
Proposal 2. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for 2010 was ratified by the stockholders, by the votes set forth in the table below.
         
FOR   AGAINST   ABSTAIN
239,377,084
  5,136,751   147,515
Proposal 3. A stockholder proposal requesting a report on political contributions was rejected by the stockholders, by the votes set forth in the table below.
             
FOR   AGAINST   ABSTAIN   BROKER NON-VOTES
75,598,836   104,415,505   47,524,406   17,122,603
Proposal 4. A stockholder proposal requesting the board adopt an independent board chair policy was rejected by the stockholders, by the votes set forth in the table below.
             
FOR   AGAINST   ABSTAIN   BROKER NON-VOTES
36,678,858   190,674,037   185,852   17,122,603

2


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
         
  Express Scripts, Inc.
 
 
By  /s/ Keith J. Ebling    
  Name:   Keith J. Ebling   
  Title:   Executive Vice President and General Counsel   
 
Dated: May 7, 2010

3